SynthesisPloS one2018

Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis.

Jae Heon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.